Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system

Human Gene Therapy

Volumn 10, Issue 7, 1999, Pages 1197-1206

  Wahlfors, J Jarmo ^a   Morgan, Richard A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; PLASMID DNA; VIRUS VECTOR;

ALPHA VIRUS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE INSERTION; GENE STRUCTURE; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HYBRID; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN SYNTHESIS; RETROVIRUS; SOUTHERN BLOTTING; VIRION;

ALPHAVIRUS; CELL LINE; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR IX; FACTOR VIII; GENE EXPRESSION; GENETIC VECTORS; HUMANS; PLASMIDS; PROMOTER REGIONS (GENETICS); RETROVIRIDAE; TRANSFECTION; TRANSGENES;

EID: 0033135165     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018184     Document Type: Article

References (28)

1. BRINSTER, R.L., ALLEN, J.M., BEHRINGER, R.R., GELINAS, R.E., and PALMITER, R.D. (1988). Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 85, 836-840.
2. BUCHMAN, A.R., and BERG, P. (1988). Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8, 4395-1405.
3. CHEN, L., PERLICK, H., and MORGAN, R.A. (1997). Comparison of retroviral and adenoassociated viral vectors designed to express human clotting factor-IX. Hum. Gene Ther. 8, 125-135.
4. CHUAH, M.K.L., VANDENDRIESSCHE, T., and MORGAN, R.A. (1995). Development and analysis of retroviral vectors expressing human factor VIII as a potential gene-therapy for hemophilia A. Hum. Gene Ther. 6, 1363-1377.
5. CONNELLY, S., GARDNER, J.M., McCLELLAND, A., and KALEKO, M. (1996). High-level tissue-specific expression of functional human factor VIII in mice. Hum. Gene Ther. 7, 183-195.
6. FRAIN, M., HARDON, E., CILIBERTO, G., and SALA-TREPAT, J.M. (1990). Binding of a liver-specific factor to the human albumin gene promoter and enhancer. Mol. Cell. Biol. 10, 991-999.
7. FRIEDMANN, T. (1996). Human gene therapy - an immature genie, but certainly out of the bottle. Nature Med. 2, 144-147.
8. GROSVELD, F., VAN ASSENDELFT, G.B., GREAVES, D.R., and KOLLIAS, G. (1987). Position-independent, high-level expression of the human beta-globin gene in transgene mice. Cell 51, 975-985.
9. JALLAT, S., PERRAUD, F., DALEMANS, W., BALLAND, A., DIETERLE, A., FAURE, T., MEULIEN, P., and PAVIRANI, A. (1990). Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines. EMBO J. 9, 3295-3301.
10. JONSSON, J., FORESMAN, M., WILSON, N., and McIVOR, R. (1992). Intron requirement for expression of the human purine nucleoside phosphorylase gene. Nucleic Acids Res. 20, 3191-3198.
11. JONSSON, J.J., HABEL, D.E., and McIVOR, R.S. (1995). Retrovirus-mediated transduction of an engineered intron-containing purine nucleoside phosphorylase gene. Hum. Gene Ther. 6, 611-623.
12. KURACHI, S., HITOMI, Y., FURUKAWA, M., and KURACHI, K. (1995). Role of intron I in expression of the human factor IX gene. J. Biol. Chem. 270, 5276-5281.
13. LI, K.J., and GAROFF, H. (1996). Production of infectious recombinant Moloney murine leukemia-virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors. Proc. Natl. Acad. Sci. U.S.A. 93, 11658-11663.
14. LI, K.J., and GAROFF, H. (1998). Packaging of intron-containing genes into retrovirus vectors by alphavirus vectors. Proc. Natl. Acad. Sci. U.S.A. 95, 3650-3654.
15. LOZIER, J.N., YANKASKAS, J.R., RAMSEY, W.J., CHEN, L., BERSCHNEIDER, H., and MORGAN, R.A. (1997). Gut epithelial-cells as targets for gene-therapy of hemophilia. Hum. Gene Ther. 8, 1481-1490.
16. MILLER, A.D. (1997). Development and applications of retroviral vectors. In Retroviruses. J.M. Coffin, S.H. Hughes, and H.E. Varmus, eds. (Cold Spring Harbor Laboratory Press, Plainview, NY) pp. 437-473.
17. MILLER, A., and ROSMAN, G. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
18. MILLER, A., BENDER, M., HARRIS, E., KALEKO, M., and GELINAS, R. (1988). Design of retrovirus vectors for transfer and expression of the human beta-globin gene. J. Virol. 62, 4337-4345. [Published erratum appears in J. Virol. 1989;63(3):1493].
19. NAKAI, H., HERZOG, R.W., HAGSTROM, J.N., WALTER, J., KUNG, S.H., YANG, E.Y., TAI, S.J., IWAKI, Y., KURTZMAN, G.J., FISHER, K.J., COLOSI, P., COUTO, L.B., and HIGH, K.A. (1998). Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91, 4600-4607.
20. ONODERA, M., YACHIE, A., NELSON, D.M., WELCHLIN, H., MORGAN, R.A., and BLAESE, R.M. (1997). A simple and reliable method for screening retroviral producer clones without selectable markers. Hum. Gene Ther. 8, 1189-1194.
21. PALMER, T., THOMPSON, A., and MILLER, A. (1989). Production of human factor IX in animals by genetically modified skin fibroblasts: Potential therapy for hemophilia B. Blood 73, 438-445.
22. PALMITER, R.D., SANDGREN, E.P., AVARBOCK, M.R., ALLEN, D.D., and BRINSTER, R.L. (1991). Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. U.S.A. 88, 478-482.
23. SADELAIN, M., WANG, C., ANTONIOU, M., GROSVELD, F., and MULLIGAN, R. (1995). Generation of a high-liter retroviral vector capable of expressing high levels of the human beta-globin gene. Proc. Natl. Acad. Sci. U.S.A. 92, 6728-6732.
24. SHIMOTOHNO, K., and TEMIN, H.M. (1982). Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector. Nature (London) 299, 265-268.
25. SINGER-SAM, J., KEITH, D.H., TANI, K., SIMMER, R.L., SHIVELY, L., LINDSEY, S., YOSHIDA, A., and RIGGS, A.D. (1984). Sequence of the promoter region of the gene for human X-linked 3-phosphoglycerate kinase. Gene 32, 409-417.
26. SORGE, J., and HUGHES, S.H. (1982). Splicing of intervening sequences introduced into an infectious retroviral vector. J. Mol. Appl. Genet. 1, 547-559.
27. WAHLFORS, J.J., XANTHOPOULOS, K.G., and MORGAN, R.A. (1997). Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells. Hum. Gene Ther. 8, 2031-2041.
28. WANG, J.M., ZHENG, H., SUGAHARA, Y., TAN, J., YAO, S.N., OLSON, E., and KURACHI, K. (1996). Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle-cells. Hum. Gene Ther. 7, 1743-1756.